ALNY
AlnylamANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ALNY vs peer average
86/100
ALNY vs. peer average (A vs. C)
Grade spread
B 1 · C 6 · D 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
IONS is the first available peer comparator.
RNA‑targeted therapeutics pioneer with complementary antisense approach; useful comparator for commercializing nucleic‑acid drugs.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ALNY
Alnylam
IONS
Ionis
Grade
A
C
Momentum
11
5
Value
59
41
Sentiment
100
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs IONS
ALNY / IONS
Grade Position
Above peers
ALNY vs. peer average (A vs. C)
86/100
Momentum
11
ALNYValue
59
ALNYSentiment
100
ALNYRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ALNY
IONS is the first peer returned for this comparison set.

